8th annual report: Down year for launches
In a challenging 2009 for products with $100+ million in sales during their first full year of U.S. availability, UCB stood out with two new drug introductions and was joined by GlaxoSmithKline, Astellas, and Cephalon as marketers of relatively successful newcomers.
By Steven Niles

To the point
PR prescription
By Christiane Truelove

Long-range transmission
Marketers must strike a careful balance between centralized and localized control and maintain a consistent message across cultures, regions, and regulatory regimes when managing global brands..
By Joshua Slatko

Follow that sample
Pharmaceutical companies are already taking into account the impact that the federal requirement to report sampling will have.
By Colette Pilkus

Simplify and fortify
Pharmaceutical marketers have an important role to play in easing the information overload burdening oncology professionals and patients.
By Gina-Louise Monari



Sales & marketing
Teva Pharmaceutical Industries Ltd. has admitted that the physician prescribing information included with packages of Gianvi did falsely claim that the ethinyl estradiol in the product was stabilized by Bayer’s patented “betadex as a clathrate” formulation.
By Joshua Slatko

Business
Major pharmaceutical and biotechnolgy companies are moving their emerging markets strategies forward in regions as diverse as South America, South Africa, and South Korea.
By Steven Niles

The Leader's Edge: Can we text?
Sander Flaum, managing partner, Flaum Partners, discusses why today’s leaders must be aware of the changes in communication and the impact it is having on business today.
By Sander Flaum

People on the Move
Bausch + Lomb is investing in leadership within its surgical division and Asia-Pacific region.
By Gina-Louise Monari

Ad Agency Update
Grey Healthcare Group is ramping up its digital resources with the launch of a Digital Health Assessment tool.
By Gina-Louise Monari

Pitch Therapy: All Hands on Deck
Mark Schnurman, pitch consultant and founder of Filament Inc., lays out the pros and cons of the two philosophies of deck writing.
By Mark Schnurman, pitch consultant and founder of Filament Inc.

Interactive & digital marketing
The U.S. Department of Health and Human Services has launched a new online tool that aims to help consumers take control of their healthcare by connecting them to new information and resources that will help them access quality, affordable healthcare coverage.
By Joshua Slatko

FDA Focus
FDA has unveiled a new source of information for patients and healthcare professionals regarding the safety of recently approved drugs and biologics.
By Steven Niles

Drug Approvals
Following priority reviews, FDA has approved two cancer drugs: Novartis’ Tasigna for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia patients and Sanofi-Aventis’ Jevtana for advanced hormone-refractory prostate cancer.
By Gina-Louise Monari

Oncology Market Soars in China
Multinational companies are gaining momentum with new, targeted therapies.
By Steven Gavel, global marketing director, Oncology, Product and Portfolio Management, IMS Health

Packaging enhances the Toviaz experience
Pfizer Inc.’s packaging for Toviaz ensures a more comprehensive and secure brand experience on behalf of patients and healthcare professionals.
By Gina-Louise Monari